![Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife](https://iiif.elifesciences.org/lax/23785%2Felife-23785-fig7-v1.tif/full/,1500/0/default.jpg)
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife
![Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion - ScienceDirect Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006899323003840-ga1.jpg)
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion - ScienceDirect
![Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F164_2020_431/MediaObjects/500126_1_En_431_Fig1_HTML.png)
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
![Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-88118-6/MediaObjects/41598_2021_88118_Fig7_HTML.png)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
![IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor](https://pub.mdpi-res.com/ijms/ijms-24-07042/article_deploy/html/images/ijms-24-07042-g001.png?1681189964)
IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
![The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322319313794-gr1.jpg)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
![Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities](https://www.mdpi.com/molecules/molecules-25-05092/article_deploy/html/images/molecules-25-05092-g001.png)
Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
![IJMS | Free Full-Text | αN-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers IJMS | Free Full-Text | αN-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers](https://pub.mdpi-res.com/ijms/ijms-24-00582/article_deploy/html/images/ijms-24-00582-ag.png?1672321906)
IJMS | Free Full-Text | αN-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers
![The complex opioid neurotransmitter system The endogenous opioid system... | Download Scientific Diagram The complex opioid neurotransmitter system The endogenous opioid system... | Download Scientific Diagram](https://www.researchgate.net/publication/12812655/figure/fig3/AS:421880118157313@1477595466223/The-complex-opioid-neurotransmitter-system-The-endogenous-opioid-system-blue-oval.png)
The complex opioid neurotransmitter system The endogenous opioid system... | Download Scientific Diagram
![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-ga1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects](https://www.mdpi.com/molecules/molecules-28-00346/article_deploy/html/images/molecules-28-00346-g001.png)
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
![Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances](https://www.science.org/cms/asset/1ecffb53-d01f-495c-9d1f-453a09d7bde5/aax9115-f1.gif)
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
![Molecular insights into the mechanism of sugar-modified enkephalin binding to opioid receptors - ScienceDirect Molecular insights into the mechanism of sugar-modified enkephalin binding to opioid receptors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1476927122001633-ga1.jpg)
Molecular insights into the mechanism of sugar-modified enkephalin binding to opioid receptors - ScienceDirect
![Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype - Drakopoulos - 2022 - ChemMedChem - Wiley Online Library Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype - Drakopoulos - 2022 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/ca843b59-192f-425c-a562-ddce8aceae4d/cmdc202200169-toc-0001-m.jpg)
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype - Drakopoulos - 2022 - ChemMedChem - Wiley Online Library
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/949a9b01-3f7c-4aa7-bc00-2e80cd815320/jnc14612-fig-0005-m.jpg)